- The report features Sage Therapeutics, Inc.' s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons To Buy- Evaluate Sage Therapeutics, Inc.' s strategic position with total access to detailed information on its product pipeline- Gain strategically significant competitor information, analysis, and insights to formulate effective R & D strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Identify and understand important and diverse types of therapeutics under development for Sage Therapeutics, Inc.- Identify potential new clients or partners in the target demographic- Plan mergers and acquisitions effectively by identifying key players and it ' s most promising pipeline therapeutics- Devise corrective measures for pipeline projects by understanding Sage Therapeutics, Inc.' s pipeline depth and focus of pipeline therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Buy a Sample copy of This Report @ http:// www. radiantinsights. com / research / sage-therapeutics-inc-productpipeline-review-2016 / request-sample
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Sage Therapeutics, Inc. Snapshot 5 Sage Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Sage Therapeutics, Inc.- Research and Development Overview 6 Key Therapeutic Areas 6 Sage Therapeutics, Inc.- Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products- Monotherapy 10 Sage Therapeutics, Inc.- Pipeline Products Glance 11 Sage Therapeutics, Inc.- Late Stage Pipeline Products 11 Phase III Products / Combination Treatment Modalities 11 Sage Therapeutics, Inc.- Clinical Stage Pipeline Products 12 Phase II Products / Combination Treatment Modalities 12 Phase I Products / Combination Treatment Modalities 13 Sage Therapeutics, Inc.- Early Stage Pipeline Products 14 IND / CTA Filed Products / Combination Treatment Modalities 14 Preclinical Products / Combination Treatment Modalities 15 Discovery Products / Combination Treatment Modalities 16 Sage Therapeutics, Inc.- Drug Profiles 17 sepranolone 17 Product Description 17 Mechanism of Action 17 R & D Progress 17 SAGE-217 20 Product Description 20 Mechanism of Action 20 R & D Progress 20